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Background: Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is relatively common in children
with limited evidence for treatment. The Phil Parker Lightning Process (LP) is a trademarked intervention,
which >250 children use annually. There are no reported studies investigating the effectiveness or possible side
effects of LP.
Methods: The trial population was drawn from the Bath and Bristol NHS specialist paediatric CFS or ME service. The
study was designed as a pilot randomized trial with children (aged 12 to 18 years) comparing specialist medical
care with specialist medical care plus the Lightning Process. Integrated qualitative methodology was used to
explore the feasibility and acceptability of the recruitment, randomization and interventions.
Results: A total of 56 children were recruited from 156 eligible children (1 October 2010 to 16 June 2012).
Recruitment, randomization and both interventions were feasible and acceptable. Participants suggested changes
to improve feasibility and acceptability and we incorporated the following in the trial protocol: stopped collecting
6-week outcomes; introduced a second reminder letter; used phone calls to collect primary outcomes from
nonresponders; informed participants about different approaches of each intervention and changed our
recommendation for the primary outcome for the full study from school attendance to disability (SF-36 physical
function subscale) and fatigue (Chalder Fatigue Scale).
Conclusions: Conducting randomized controlled trials (RCTs) to investigate an alternative treatment such as LP is
feasible and acceptable for children with CFS or ME. Feasibility studies that incorporate qualitative methodology
enable changes to be made to trial protocols to improve acceptability to participants. This is likely to improve
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Chronic fatigue syndrome or myalgic encephalomyelitis
(CFS/ME) in children is relatively common, affecting
between 0.1 and 2% of secondary school children [1-5].
It is potentially serious, with over 50% of children bed-
bound at some stage and an average school absence of
one academic year [6,7]. CFS/ME is defined as ‘genera-
lized fatigue, causing disruption of daily life, persisting
after routine tests and investigations have failed to iden-
tify an obvious underlying “cause”’ [8]. National Institute
of Health & Clinical Excellence (NICE) guidelines re-
commend a minimum duration of 3 months of fatigue
before making a diagnosis in children [9].
Specialist medical care for CFS/ME follows evidence-
based approaches as recommended in NICE guidelines
[9]. This evidence includes two randomized controlled
trials (RCTs) comparing cognitive behavioural therapy
with waiting list (delayed cognitive behavioural therapy)
[10,11] or internet-based CBT with normal care [12],
one trial comparing family-focused cognitive behavioural
therapy with psycho-education [13] and one observational
study comparing outcomes in children who chose out-
patient multidisciplinary rehabilitative treatment (graded
activities or exercises and supportive care) instead of sup-
portive care alone [14].
The Phil Parker Lightning Process® (LP) is a trade-
marked intervention that is used for a variety of conditions
including CFS/ME. It was developed from osteopathy, life
coaching and neurolinguistic programming. The LP trains
individuals to recognize when they are stimulating or trig-
gering unhelpful physiological responses and to avoid
these, using a set of standardized questions, new language
patterns and physical movements with the aim of im-
proving a more appropriate response to situations (www.
lightningprocess.com). The intervention includes three
group sessions on consecutive days where participants are
taught theories and skills, which are then practised
through simple steps, posture and coaching. Families cur-
rently pay approximately £620 to attend the Lightning
Process course. Even though more than 250 children per
year use the LP as an intervention for their CFS/ME, there
are currently no reported studies investigating the effec-
tiveness or possible side effects of LP in children.
Feasibility studies are used to estimate important study
variables, for example standard deviation of the outcome
measure, the willingness of participants to be random-
ized and the number of eligible patients [15]. Recruit-
ment can be improved by audio-recording recruitment
consultations, evaluating information exchange, and re-
training recruiters to improve collection of informed
consent, rates of randomization and acceptance of allo-
cation [16,17]. In this study, we report on the feasibility
and acceptability of recruiting families into a trial involv-
ing an alternative intervention (the Lightning Process)for CFS/ME to inform the design of a full-scale, ad-




Children were recruited between October 2010 and June
2012 at initial clinical assessment appointments con-
ducted by the Bath and Bristol specialist paediatric CFS/
ME service. This service provides assessment and treat-
ment for more than 250 children each year. Most pa-
tients are from South Gloucestershire, Bristol, Somerset
and Wiltshire, but children and young people from across
the UK also receive assessment and treatment. Children
were eligible for this study if they were diagnosed with
CFS/ME according to NICE diagnostic criteria [9], they
were mildly to moderately affected (able to attend clinic
appointments), were 12 to 18 years old and were suffi-
ciently literate in the English language to understand the
patient information sheet.
Figure 1 describes the recruitment process. Eligible
children and their families were identified by the clin-
ician conducting the assessment. If the child and his or
her family were willing to find out more about the study
a researcher contacted the family and arranged to visit
them at a convenient location (usually at home) to
discuss and provide further information, including: the
study rationale, the uncertainties about the effectiveness
of either intervention, the known advantages or disad-
vantages of the interventions, the options available out-
side the RCT, and the right not to take part or withdraw
at any time. Those willing to take part were randomized
to receive either specialist medical care or to specialist
medical care plus the Phil Parker Lightning Process (LP).
Allocation was minimized [18] by sex and age retaining a
probabilistic element using a computer-generated random
number sequence, and was implemented using an auto-
mated telephone randomization service provided by the
Bristol Randomized Trials Collaboration to ensure con-
cealment from clinical staff undertaking recruitment.
Interventions
Specialist medical care
Children and their families were offered a variety of
treatment options [9] centred around graded activity.
Participants typically received a follow-up phone call
2 weeks after assessment followed by family-based re-
habilitation consultations at approximately 6 weeks, 3
months and 4.5 months (each lasting one hour). The
number and timing of the sessions were agreed with the
child and family, and varied depending on the needs and
goals of the child. Other interventions, such as cognitive
behavioural therapy or graded exercise therapy (GET),
were offered to children if needed (usually if there were
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Figure 1 Protocol flow chart.
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related, respectively).
Specialist medical care plus the Lightning Process
In addition to specialist medical care, children and their
parents in this arm were asked to read information
about the Lightning Process on the internet. They then
followed the usual LP procedure (reading the introduc-
tory LP book or listening to it in CD form) and complet-
ing an assessment form to identify goals and describe
what was learnt from the book. On receiving completed
forms, an LP practitioner telephoned the children to
check whether they were ready to attend an LP course.
The courses were run with two to four children over
three sessions (each 3 hours 45 minutes) on three con-
secutive days. During the group sessions, children had a
theory session (elements of the stress response, how the
mind and body interact and how thought processes can
be helpful or negative) and a practical session to put
skills into practice. Children and their families then had
two follow-up phone calls with the LP practitioner
within 2 weeks of and 6 to 8 weeks after the LP course.The purpose of the follow-up was to provide support
and to check that the participant had understood what
was covered on the course, were able to apply the tools
and could identify when they needed to use LP, and to
clarify and discuss areas of uncertainty.Outcome assessment
The following inventories were completed by children
just before their clinical assessment (baseline) and follow-
up (6 weeks and 3, 6 and 12 months): 11-item Chalder
Fatigue Scale [19]; visual analogue pain rating scale; the
SF-36 [20]; the Spence Children’s Anxiety Scale [21]; the
Hospital Anxiety and Depression Scale (HADS) [22],
a single-item inventory on school attendance and the
EQ-5D five-item quality-of-life questionnaire [23]. At
the start of the study, follow-up times were 6 weeks
and 3, 6 and 12 months. We estimate that these question-
naires take approximately 20 to 30 minutes to complete.
However, the 6-week follow-up was dropped following
feedback from parents about the excessive burden of com-
pleting questionnaire packs.
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lowing questionnaires at baseline: socioeconomic status
(education and employment), an adapted 4-item Work
Productivity and Activity Impairment and General Health
(WPAI:GH) questionnaire [24] and an adapted existing
health resource-use questionnaire, which asked parents
about the health service (for example, GP or specialist
care), educational service (for example, school counsellor)
and travel costs most relevant to the CFS/ME population.
The latter two questionnaires were also completed at 3, 6
and 12 months follow-up.
Reminders were sent out at 2 weeks if follow-up ques-
tionnaires had not been returned. To improve follow-up
rates we sent out a reduced set of questionnaires (SF-36,
Chalder Fatigue Scale and school attendance question)
with the reminder letter two weeks after the initial ques-
tionnaires were sent. We introduced a phone call to
nonresponders two weeks after the reminder was sent,
to complete the reduced questionnaire set over the
telephone.
Qualitative research
In-depth interviews were undertaken with parents on
three occasions (after assessment but prior to randomi-
zation, after randomization, and after the intervention)
to form ‘case studies’. Children were interviewed once at
one of these times. We used purposive sampling to en-
sure that interviews included a range of informants, in
terms of socioeconomic circumstances, age, sex, ethni-
city and families from both intervention arms (maximum
variation sampling) [25].
Interviews were conducted at a location of the parent’s
choice and were semistructured following a checklist of
topics to ensure consistency, but flexible enough to
allow parents and children to raise issues of importance.
Interviews explored the recruitment process; the provi-
sion of study and intervention information; participants’
beliefs, expectations, preferences and experiences of the
interventions; reasons for accepting or declining partici-
pation; and the acceptability of the outcome measures.
Interviews lasted approximately 20 to 60 minutes with
parents and 20 minutes with children. All interviews
were audio-recorded with consent, transcribed verbatim,
and anonymized.
Observations (followed by discussions with a resear-
cher) were made of children and parents completing the
questionnaires at follow-up to highlight any difficulties
or misunderstandings [26]. These children were recrui-
ted opportunistically when the study team was aware that
a questionnaire was due for completion. Participants were
observed completing follow-up questionnaires in their
own homes.
All recruitment consultations were audio-recorded to
document the interaction between recruiter and potentialparticipant, so as to explore information provision, re-
cruitment techniques, patient treatment preferences and
randomization decisions and to identify recruitment diffi-
culties and support change [16,17].
Data analysis
We recorded the number of potentially eligible partici-
pants attending the clinic, the number assessed for eligi-
bility, and the number of eligible patients who consented
and were randomized. We compared characteristics of
eligible patients who were and were not randomized
using appropriate descriptive statistics (that is, mean and
standard deviation or median and interquartile range
(given as first and third quartile, Q1, Q3) for continuous,
and number and percent for categorical variables re-
spectively). As the aim of this study was to assess the
feasibility of a future definitive trial, we did not under-
take a formal sample size calculation.
Qualitative data analysis was an ongoing and iterative
process, commencing soon after data collection, and in-
formed further sampling and data collection. Interview
transcripts and observation notes were imported into
NVivo (version 9) where they were systematically as-
signed codes and analyzed thematically to identify themes
using techniques of constant comparison [27]. Individuals
exhibiting contrasting attitudes (‘negative cases’) were
studied in detail to understand reasons underlying such
contrasts and to gain a deeper understanding of the data
and findings [28]. Recruitment to trial consultations were
purposefully selected for analysis according to whether or
not the study participant accepted randomization, dif-
ferent times in the study, and those that highlighted issues
of study acceptability (intervention crossover and study
withdrawal). Recruitment to trial consultations was ana-
lyzed for content and presentation of information relating
to the interventions using techniques of content analysis
[29]. Two members of the research team analyzed ap-
proximately 10% of the qualitative data independently
to compare coding and enhance dependability of find-
ings. Descriptive accounts were produced, and theore-
tical explanations for behaviours, opinions and decisions
developed.
Serious adverse events
Serious adverse events were reported by clinicians from
the clinical team or members of the research team to
the principle investigator and the sponsor within 24 hours.
All serious adverse events were reviewed by the research
and development committee.
Ethical review
A favourable ethical opinion was given on the 8th Sep-
tember 2010, reference 10/H0206/32, by South West 2
Local Research Ethics Committee. A favourable ethical
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to study documents and protocol.
Results
Feasibility of recruitment
Figure 2 describes the flow of children through the
study. Between 1 October 1 2010 and 17 June 2012, a
total of 312 children attended clinic appointments. Of
the 297 assessed for eligibility, 141 were ineligible. The
majority (38) did not have CFS/ME, lived too far away
for follow-up (43) or were too young (36). Of the 157
eligible children, 28 declined to participate at the clinical
assessment. The majority were ‘not interested’ (15) or
said it was ‘too much’ (7). Fifty-nine families were given
study information sheets at the clinic appointment but
did not return them and it was assumed that they did
not want to take part in the study.Allocated to SMC= 28
Received SMC only= 25
Received SMC + LP =2





Did not provide follow-up data = 1 
Withdrawn from study =1 








Assessed for eligibility = 2
Figure 2 CONSORT diagram showing flow through study for patientsSixty-nine families agreed to further contact from the
research officer and of these 13 children declined ran-
domization. Seven declined further involvement prior to
the recruitment to trial consultation and five declined
participation at or after the consultation. The number of
eligible children who were randomized was therefore
56/156 (35.9%).
Table 1 shows that the baseline characteristics of the
children who were recruited and were not recruited
were similar. The mean age of recruited children was
14.8 years, 76.4% were girls and the median time from
onset of illness to assessment was 12 months.
Acceptance of treatment arm
All 56 participants accepted the allocation at the ran-
domization appointment. From these, 47/56 received the
treatment as allocated. During the study, 3/28 (10.7%) inated to SMC+LP=28
ived SMC + LP = 19
ot receive SMC+LP = 3 (declined)
ing LP = 6
ot provide follow-up data = 1
drawn from study = 1 
ntinued intervention = 1
= 69
Declined= 13 
Prior to contact = 1, At phone call 
prior to randomization = 7, 
Declined at randomization=5
Did not return consent forms = 59
Declined to participate= 28
Doing additional treatment=1; No 
groups=2; Too much=7; Going to 
do LP=1; Doesn’t want follow-





Not Eligible= 141 
Reason not recorded = 4; 
Learning difficulty = 1; Not CFS=
38; Too young = 36; Too old = 2; 
Too far= 43; Severe= 11; Not ill 
anymore = 3; Previous LP = 3
assessed for eligibility (1 October 2010 to 16 June 2012).
Table 1 Characteristics of eligible patients who were and were not recruited
Recruited to SMILE n = 56 Eligible but not recruited n = 100
Mean (standard deviation) Mean (standard deviation)
Age (years) 14.8 (1.6) 14.8 (1.6)
Female 42 (76.4%) 71 (73.2%)
Median (Q1 to Q3) Median (Q1 to Q3)
Time to assessment (months) 12 (7 to 21) 12 (6 to 24)
Chalder fatigue score (0 to 33) 25 (23 to 27) 25 (21 to 28)
SF-36 physical function (0 to 100) 55 (44 to 65) 55 (35 to 70)
Anxiety (Spence Children’s Anxiety Scale) (0 to 90) 35 (21 to 52) 33 (21 to 46)
Number of symptoms (0 to 14) 9 (7 to 10) 9 (7 to 10)
Anxiety (HADS) (0 to 21) 10.5 (7.5 to 13) 9 (7 to 12)
Depression (HADS) (0 to 21) 8 (6 to 10) 8 (5 to 11)
Visual analogue pain 52 (35 to 73) 49 (15 to 68)
School attendance in the previous week: n (%) n (%)
None 5 (9.3%) 24 (24.0%)
10% 7 (13.0%) 4 (4.0%)
20% 4 (7.4%) 6 (6.0%)
40% 9 (16.7%) 12 (12.0%)
60% 13 (24.1%) 28 (28.0%)
80% 13 (24.1%) 21 (21.0%)
100% 3 (5.6%) 3 (3.0%)
Not applicable 0 (0.0%) 2 (2.0%)
HADS, Hospital Anxiety and Depression Scale.
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LP (one decided not to proceed after reading further in-
formation and two were unable to attend the course). Six
participants were pending LP treatment at the time of
analyses. We were aware that three families in the specia-
list medical care arm subsequently went on to obtain the
LP privately and therefore did not receive this allocation.
One of these families did not have specialist medical care.
Follow-up rates
In the first 12 months of the study, we followed up 10/18
families (55.6%) at 6 months. We then implemented
changes to the protocol to improve follow-up rates includ-
ing a phone call to nonresponders to collect the primary
and secondary outcome measures (SF-36 and Chalder
Fatigue Scale). This was successful and from March 2011
to December 2011, follow-up rates of the 24 children
assessed prior to January 2012 who should have had
6 month follow-up data by July 2012 were 22/24 (91.7%).
Qualitative research findings
Participants
Thirteen mothers and twelve children were interviewed.
One mother interviewed did not consent to her childbeing interviewed and two children (a sixteen-year-old
boy and a fourteen-year-old girl) declined an interview.
Five mothers were interviewed at all three times to form
case studies. The remaining eight mothers took part in
one-off interviews, four after randomization and four
after the intervention. Of the twelve children interviewed,
five were interviewed after randomization and seven after
the intervention. Three of the children were boys and nine
were girls. Seven children in the qualitative sample were
randomized to the specialist medical care and Lightning
Process arm and six to the specialist medical care arm of
the study.
Ten further participants were observed completing
questionnaires, and were asked to give verbal feedback
on questionnaire acceptability as they progressed through
the questionnaire. Questionnaire observations were con-
ducted with four mothers, one father and five children
(four boys and one girl).
Acceptability of study discussion at clinic
Most families found the initial discussion in clinic about
the study acceptable. Families recognized that time was
limited at the end of the clinical consultation, and some
families appreciated taking the information sheets home
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of clinical information about their child’s CFS/ME.
Parent (P)4: ‘I think we got what we needed, we just
got the basics and I’m always quite happy to
contribute to research if we can, if it helps’.
(Prior to randomization)Young Person (YP)88: ‘I think also we didn’t get much
[oral] information. [Researcher: Did she give you the
information to take?] Yes, to take with us because we
were, like, running over time, so she said, ‘Have this,’
and we just went. We didn’t look at it until quite a bit
after’. (Post randomization)
Study information sheets
Study information sheets were largely viewed by mothers
as being informative and understandable. The flow chart
diagram and data tables included in the information
sheet were perceived as positive.
P4: ‘The diagrams really, really breaks down what the
process is; it makes it very easy to see… that would be
more than enough information to make a decision on,
and it answers all the questions about privacy and
what the purpose is and what’s going to happen’.
(Post randomization)
One parent (P5) felt that although the information
sheet provided, ‘everything they needed to know,’ it was
at the same time slightly overwhelming:
P5: ‘I think it should be simplified, because I think it is
quite scary to read the pack with the interviews; it is
quite intense and it was quite off-putting, to be honest’.
(Prior to randomization)
Most children relied on their parent’s verbal explana-
tion of the patient information sheet, especially those
aged 12 to 14 years, primarily because it was perceived
as long, difficult to understand, repetitive in places and
not visually appealing to 12 to 18 year olds.
YP38: ‘I thought they were quite long, given that we’re
reading about CFS and I find it very hard to
concentrate so it took me a long time to read
through the whole thing because I had to read it
through quite a few times to actually understand
it… and I actually ended up asking Mummy to
read it herself and then tell me verbally; like, sum
it up to me verbally, which was better, so that I
could really understand… other than the graphs at
the end, I didn’t get, but Mummy then worked
them out’. (Post randomization)YP35: ‘I think that when you look at it you
don’t … it doesn’t look that interesting so … it
makes you not interested in reading it’.
(Post randomization)
A few children felt the term ‘interviews’ was too
formal and somewhat ‘scary’, reminding them of a for-
mal interview situation where they would be put on
the spot.
YP22: ‘Because of all the different interviews
with all the different people: she said I had
to have a few 20-minute interviews with different
people and I’m not very confident, so…’.
(Prior to randomization)
Recruitment consultations
Ten audio-recordings of recruitment consultations were
analyzed. Consultations were good in terms of the
provision of study information and were conducted at a
good pace with a good rapport. However, discussion of
the interventions tended to be weighted towards the
Lightning Process rather than the specialist medical care.
This was fed back to the research officer through written
information and discussion and suggestions were made
to redress the balance and incorporated in future re-
cruitment consultations.
The majority of families were positive about the re-
cruitment consultation. Sufficient information was pro-
vided, families were able to ask questions, understood
what the study was about and what would happen if they
decided to participate.
YP38: ‘It was really good, it was really useful and it
really reassured me and my parents… I was worried
that somebody was kind of just going to come in
and do a sales pitch, as it were, to us, which
probably would have put me off even more’.
(Post randomization)
Two parents felt that a lot of resources had been used
to explain the study and because they were randomized
to the specialist medical care arm, they felt that they had
been given information about the Lightning Process that
they didn’t need.
P2: ‘I suppose if anything it was slightly overkill, in
that we’d already had that information from [the
CFS/ME Team] and we’d consented [to contact] to the
study, we were up, we were up for it. So it was, it was
very nice to see [the research officer] and to have more
information and talk about it in more detail, but I
think we had already decided that we were going for
it’. (Post randomization)
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research officer immediately after randomization; seven
families felt this was a good thing.
YP38: ‘I think my mum and I were pretty keen to find
out once we knew we were going to do it, what group I
was in… I was happy to find that out then, I think,
because once you’ve said, ‘Yes,’ [to the study] that’s all
you’d really worry about’. (Post randomization)
However, one parent would have preferred to receive
the allocation by letter.
P33: ‘I think there’s probably a better way: you get sent
a letter telling you what it is, so you can deal with
your disappointment without somebody sitting there,
somebody you don’t know, and you’re not having to
hide a reaction you might feel’. (Post randomization)
Conflict between interventions
Four parents and children randomized to the specialist
medical care and Lightning Process arm described dif-
ferences between the two interventions in terms of the
language and approach used, which meant that the ap-
proaches conflicted with each other.
P7: ‘A bit confused. Not quite so bad as we were… I
was talking to healthcare professional A, from the ME
clinic. I said it feels like we were going to ME clinic
and that was fine and we were dealing with it that
way, and then we were given this opportunity, which is
fantastic, but it felt like after we’d done it, it felt a bit
confused as where we were supposed to go from then’.
(Post intervention)P9: ‘It has been a bit confusing, I have to say, because
obviously we have got the [Lightning Process
practitioners] approach, where, “Right, finally, done
this, now you don’t need to do the pacing; you can just
go back to school full time.” I think, the physical side
of things, YP9 has had to build herself up more
rather than just suddenly go back and do that’.
(Post intervention)
In light of these findings, we incorporated an expla-
nation of the potential for differences or ‘conflict’ be-
tween the two approaches in the patient information
leaflet and in the discussion prior to randomization. The
research team discussed the issue of conflict with the
CFS/ME team and the Lightning Process practitioners,
who agreed to respect the different approaches and
support parents and children. Parents and children on
subsequent courses did not report conflict. Children
appeared to cope with differences between the twoapproaches by using best practice from both to fit
with their current health needs.
YP36: ‘Doing them together is okay, but it is quite
difficult… But I will definitely keep doing the energy
thing until my body is completely healthy again and
then once my body is as healthy as any other person
my age then I am probably going to try and stick to
the Lightning Process after I am totally back at full
health’. (Post intervention)
Study burden
The number of questionnaires used at follow-up was
considered a burden by the majority of children and par-
ents interviewed and observed. Parents felt the timing of
questionnaires did not allow time for change, as they
were too close together.
P32: ‘The amount of treatment that he’s had, as such,
is totally out of proportion, as in small compared to
the amount of forms [questionnaires] that have had to
be filled in and the amount of information that we’ve
had to provide… I just find the whole thing really
confusing because they seem, we seem, to kind of get
one quite soon after the appointment … I think we’ve
had about three; I don’t know how many times they’ve
arrived’. (Questionnaire interview)
This resulted in changes to the trial protocol: the six
week follow-up questionnaire was dropped and a re-
duced set of questionnaires (SF-36, Chalder Fatigue and
school attendance) was sent with the reminder letter. If
participants had still not responded after two weeks,
they were telephoned and invited to complete the re-
duced set of questionnaires over the telephone.
Primary outcome
During the study, parents and participants commented
that the school attendance primary outcome did not ac-
curately reflect what they were able to do, particularly if
they were recruited during, or had transitioned to, A
levels during the study. This is because it was not clear
what ‘100% of expected attendance’ was. In addition, we
were aware of some participants who had chosen not to
increase school attendance despite increased activity.
Serious adverse events
Two serious adverse events were reported during this
part of the study. Both concerned admissions to hospital,
one of a child and one of a parent. Neither was related
to their involvement in the SMILE study. Both were re-
ported as per routine procedures and no action was ne-
cessary by the study team.
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It is feasible to recruit children with CFS/ME to a ran-
domized controlled trial comparing specialist medical
care with specialist medical care plus the Lightning
Process. 44.2% (69/156) of eligible children consented
for the research officer to visit them at home: of these,
81.2% (56/69) agreed to participate in the study and
were randomized. Children and their parents said that
the recruitment and randomization process was accept-
able. All families accepted the treatment arm that they
were allocated to but 3/28 (10.7%) families in the spe-
cialist medical care arm sought the Lightning Process
privately; one of these did not receive specialist medical
care. In the specialist medical care plus the Lightning
Process arm, 3/28 (10.7%) did not attend a Lightning
Process course.
Strengths and limitations
As far as we are aware, this is the first study to attempt
to investigate the feasibility and acceptability of a rando-
mized controlled trial investigating the Lightning Process
in children. We incorporated qualitative research methods
to enable us to investigate issues around randomization
and retention, as well as to explore differences bet-
ween the two treatment approaches. We analyzed audio-
recordings of recruitment consultations, which enabled us
to improve the balance between interventions in the con-
sultations to improve recruitment and retention. Inter-
viewing parents allowed us to examine difficulties parents
might experience with the treatment arms.
Recruitment rates were lower than anticipated, mean-
ing that recruitment continued for longer than planned.
This was mainly due to an underestimate of the number
of eligible patients at the start of the study (nearly half
were not eligible). However, a recruitment rate of 35.9%
does not preclude a full study [30].
Recommendations for a full study
This study suggests that trials involving 17 and 18 year
olds need to consider alternative primary outcome mea-
sures to school attendance. In addition to the difficulty
measuring change in school attendance for those transi-
tioning from GCSEs to A levels, it may be a poor out-
come measure for those who do not consider school
attendance their primary goal. We suggest that a full
study uses other primary outcomes, such as the SF-36 or
the Chalder Fatigue Scale and uses school attendance as
a secondary outcome. Future studies should consider
using different patient information sheets for children
aged 12 to 14 years than those used for older teenagers.
The word ‘interview’ should be defined more fully in
future information sheets or possibly a different word or
description used, perhaps ‘a discussion with a researcher
to get your views’. We have demonstrated that it ispossible to improve outcome data collection using a var-
iety of strategies, including telephone follow-up, and these
would need to be implemented in a full study. In addition,
we would recommend protocols to identify increased dis-
ease activity during the course of the study, such as those
used in the PACE trial [31].
Ethical acceptability
We made an assessment of whether a full study could
operate ethically. We suggest that, provided appropriate
measures remain in place or are improved (for example,
the patient information sheet) there is no reason to sup-
pose that a full study could not be ethically sound. This
is not to anticipate the outcome of reviews of relevant
research ethics committees that would be necessary be-
fore starting a full study.
The key areas for ethical consideration in any research
study with human participants can be categorized as (i)
respecting individuals’ autonomy; (ii) welfare of partici-
pants; (iii) wider societal interests [32].
i. Respect for individuals’ autonomy (and by
implication respecting potential participants’
choices) [33] was inherent in the study design by use
of: clear information; recruitment and consent
procedures that ensured voluntariness; and
confidentiality agreements. The procedures for
obtaining consent varied according to age group, to
account for the corresponding differences in
capacity [34]. To participate, parents and patients
over 16 years old had to give consent for their own
involvement. Those under 16 years provided assent
and their parent consented on their behalf. In all
cases, the research process involved a patient-
parental partnership so parents were fully aware of
their child’s participation. We recommend that a full
study should operate according to a similar policy,
or a policy of getting both assent and parental con-
sent for all patients. Comprehensible and accessible
information is essential for ensuring that both con-
sent and assent are valid, since the participant is
making a choice based on that information. Feed-
back suggests the information sheets could be im-
proved to be more age-appropriate with a better
description of interviews.
ii. Participant welfare was safeguarded throughout the
study, and the level of inconvenience minimized. For
example, the number and length of questionnaires
were reduced, as we would recommend for a full
study. No patient was deprived of any treatment
they would normally have been offered, and we
suggest that this should be the same for a full study.
iii. Any research study involving participants must be
ethically justifiable in terms of its potential wider
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moral case for conducting a full-scale study into the
effectiveness of the Lightning Process as a treatment
for CFS. This is based on the needs of children and
teenagers with CFS, the lack of evidence for the best
methods of treatment, and the fact that participating
in the trial presents relatively little burden for pa-
tients and parents.
Conclusion
Conducting an RCT to investigate an alternative inter-
vention in children with CFS/ME is feasible and accept-
able, even if the intervention is controversial and highly
publicized. This study demonstrates the importance of
feasibility studies before a full study [35]. The qualitative
methodology enabled us to understand problems with
study overload and reduce the number of questionnaires
used; and to understand conflict between the two in-
terventions, which required additional information in
the patient information sheet. Neither of these problems
would have been easily detected otherwise. This feasi-
bility study led to several changes to the proposed meth-
odology of the full study. Future research is needed to
provide more information on the Lightning Process and
differences between the Lightning Process and specialist
medical care.
Interview topic guide
These questions are to be used as prompts to ensure that
all important areas are covered
Welcome, introduction, stress confidentiality. Discuss
consent, sign form or check continues to be happy with
consent.
After assessment and before randomization
1) Can you talk me through your initial
appointment with the research nurse?
Prompts: What was said, did you understand what
was being said? Feelings?
2) What were your initial thoughts about the
study?
Prompts: What did you think when you were told
about it? Feelings? Worries? Expectations?
3) Did you know anything about the Lightning
Process before this initial appointment (for first
interview only)?
Prompts: How? Who? What did you think? What
information?
4) What did you think about the information you
were given about the study?
Prompts: What information did you get – oral and
written? Did you read it? Understand it? Did it give
you enough information? Too much? Were there
things you thought they had forgotten to include?5) Have you found out any information about the
Lightning Process since?
Prompts: Why? How? What did you find? What did
you think?
6) What are your thoughts at this stage on taking
part or not? Why?
Note: Stress that they are not being asked at this
stage but that we want to gauge their thoughts,
stress also that it makes no difference to the
interviewer.
7) If you were to take part, would you have a
preference for one of the interventions?
Prompts: Why? Issues over participation?
Engagement? What would you do if allocated the
other intervention?
8) What do you think about having treatments
allocated at random, that is, by chance?
Prompts: Why is it done? How do you feel about
this way of deciding what treatment you’ll get? Is
there a better way? Do you think you’ll be happy to
be randomized? Do you think you’re likely to get
one intervention rather than the other? Why?
9) You have now done some questionnaires at
follow-up. What did you/your child think about
the questions you were asked?
Prompts: Were there any particularly difficult
questionnaires? What did you think about the
HADS/ POMS inventory? Would you leave some
questionnaires out? Other areas that should be
covered?
After randomization and before interventions
1) Can you tell me what happened when the
research nurse visited and explained about
randomization?
Prompts: What did she say? Understandable? What
did you think? Did you understand what was going
to happen?
2) What did you think before randomization?
Prompts: Were you happy with the process?
Did you understand what was going to happen
and why?
3) Did you agree to randomization or not? Why?
4) What did you think when you got your
intervention allocation?
Prompts: How did you feel? Was it what you
expected? Wanted? Expectations of intervention?
What have you done since then?
5) You have now completed some questionnaires at
follow-up. What did you/your child think about
the questions you were asked?
Prompts: Were there any particularly difficult
questionnaires? What did you think about
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questionnaires out? Other areas that should be
covered?After intervention
1) Tell me about the intervention you received?
Prompts: What happened? What was good/bad?
What would you change? Venue? Structure of
sessions? Language used? Was it as expected?
2) Do you think you/your child have/has learnt
anything from it, if so what?
Prompts: About CFS/ME, themselves,
self-management?
3) What has happened after the intervention?
Prompts: How have you/they done? What are
you/they doing? Feeling?
4) What do you think now about being
randomized?
Prompts: Would you do it again? What do you think
about the study for others?
5) You have now completed some questionnaires at
follow-up. What did you/your child think about
the questions you were asked?
Prompts: Were there any particularly difficult
questionnaires? What did you think about the
HADS/ POMS inventory? Would you leave some
questionnaires out? Other areas that should be
covered?
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